The current head of the Food and Drug Administration, Janet Woodcock, is serving in an ‘acting’ capacity only, as her name was never nominated to the senate for confirmation. Several media outlets are now reporting her name will never be nominated because she cannot pass the confirmation process.
Ms. Woodcock (pictured left) has a rather controversial past from her career work inside the FDA which included the advanced authorization for many opioids that created a massive health crisis. She was, for all intents and purposes, the key figure inside the FDA who gave the pharmaceutical industry cart blanche authorization to create, market and distribute the pain-killing opioids that led to hundreds-of-thousands of U.S. deaths.
Senator Joe Manchin from West Virginia represents one of the constituencies hardest hit by the opioid epidemic. Manchin was not going to support Woodcock’s nomination. In a 50/50 senate, she didn’t stand a chance of confirmation.
It does not seem coincidental that Ms. Woodcock was in position as ‘acting director’ just long enough for the first COVID vaccine to gain FDA approval; and then, presto, the announcement of her dispatch. Suspicious cat remains, well, suspicious.
WASHINGTON DC – U.S. President Joe Biden’s administration has ruled out nominating Janet Woodcock as the permanent head of the Food and Drug Administration (FDA), Bloomberg News reported on Thursday, citing people familiar with the matter.
According to his report, the U.S. State Department responded en masse to all the people trapped in Afghanistan reaching out for help.
Reuters is writing today that current and former FBI officials have reversed course and said there is scant evidence that any right-wing or extremist group coordinated any attack on Capitol Hill.
People keep sending me emails about a Wall St Journal article [